|Bid||0.0750 x 0|
|Ask||0.0800 x 0|
|Day's range||0.0800 - 0.0850|
|52-week range||0.0700 - 0.2600|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
MISSISSAUGA, Ontario, November 30, 2021--MedX Health announces commercialization pilot of its teledermatology screening platform with London Medical Laboratory Ltd. in the United Kingdom.
MISSISSAUGA, Ontario, November 29, 2021--MedX Health announces its third quarter 2021 financial results.
MISSISSAUGA, Ontario, November 22, 2021--MedX convenes leading dermatologists across North America to explore clinical opportunities for its teledermatology screening platform, DermSecure.